5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.00▲ | 2.01▼ | 2.01▼ | 2.13▼ | 2.06▼ |
MA10 | 2.01▼ | 2.02▼ | 2.04▼ | 2.14▼ | 1.92▲ |
MA20 | 2.01▼ | 2.05▼ | 2.09▼ | 2.09▼ | 1.94▲ |
MA50 | 2.02▼ | 2.14▼ | 2.17▼ | 1.90▲ | 4.22▼ |
MA100 | 2.05▼ | 2.17▼ | 2.12▼ | 1.95▲ | 5.84▼ |
MA200 | 2.12▼ | 2.11▼ | 2.02▼ | 3.29▼ | 20.87▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | 0.002▲ | -0.008▼ | -0.015▼ | 0.217▲ |
RSI | 45.352▼ | 34.715▼ | 30.126▼ | 47.452▼ | 39.780▼ |
STOCH | 40.278 | 25.093 | 10.936▼ | 48.341 | 70.960 |
WILL %R | -50.000 | -86.364▼ | -90.625▼ | -88.158▼ | -36.612 |
CCI | -25.455 | -92.567 | -87.335 | -84.262 | 92.927 |
Friday, June 13, 2025 02:25 PM
This was the stock's third consecutive day of losses.
|
Thursday, June 12, 2025 02:27 PM
Shares of Inovio Pharmaceuticals Inc. INO shed 1.89% to $2.08 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP rising ...
|
Wednesday, May 28, 2025 12:16 PM
PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) has unveiled promising peer-reviewed results from its Phase 1/2 clinical trial for INO-3107, a cutting-edge DNA medicine designed to treat recurrent ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 2.05 | 2.11 | 1.99 | 2.00 | 617,314 |
12/06/25 | 2.12 | 2.15 | 2.04 | 2.08 | 733,486 |
11/06/25 | 2.27 | 2.27 | 2.11 | 2.12 | 829,195 |
10/06/25 | 2.21 | 2.335 | 2.155 | 2.25 | 934,370 |
09/06/25 | 2.33 | 2.3346 | 2.18 | 2.22 | 775,900 |
06/06/25 | 2.15 | 2.325 | 2.14 | 2.27 | 1,166,754 |
05/06/25 | 2.18 | 2.18 | 2.09 | 2.12 | 687,175 |
04/06/25 | 2.12 | 2.20 | 2.095 | 2.17 | 729,046 |
03/06/25 | 2.12 | 2.175 | 2.03 | 2.12 | 592,251 |
02/06/25 | 2.03 | 2.155 | 2.00 | 2.10 | 694,828 |
|
|
||||
|
|
||||
|
|